DK3397748T3 - Fremgangsmåde til dyrkning og konservering af Eubacterium hallii - Google Patents
Fremgangsmåde til dyrkning og konservering af Eubacterium hallii Download PDFInfo
- Publication number
- DK3397748T3 DK3397748T3 DK17701754.8T DK17701754T DK3397748T3 DK 3397748 T3 DK3397748 T3 DK 3397748T3 DK 17701754 T DK17701754 T DK 17701754T DK 3397748 T3 DK3397748 T3 DK 3397748T3
- Authority
- DK
- Denmark
- Prior art keywords
- culturing
- preserving
- eubacterium hallii
- hallii
- eubacterium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2016055 | 2015-12-31 | ||
| PCT/NL2017/050001 WO2017116235A1 (en) | 2015-12-31 | 2017-01-02 | Method for culturing and preserving eubacterium hallii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3397748T3 true DK3397748T3 (da) | 2021-05-10 |
Family
ID=56990905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17701754.8T DK3397748T3 (da) | 2015-12-31 | 2017-01-02 | Fremgangsmåde til dyrkning og konservering af Eubacterium hallii |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10806758B2 (pt) |
| EP (1) | EP3397748B1 (pt) |
| JP (1) | JP2019500035A (pt) |
| KR (1) | KR20180091100A (pt) |
| CN (1) | CN108699509A (pt) |
| AU (1) | AU2017204717A1 (pt) |
| BR (1) | BR112018013292A2 (pt) |
| CA (1) | CA3008156C (pt) |
| DK (1) | DK3397748T3 (pt) |
| RU (1) | RU2737398C1 (pt) |
| SG (1) | SG11201804847UA (pt) |
| WO (1) | WO2017116235A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017204717A1 (en) | 2015-12-31 | 2018-08-02 | Caelus Pharmaceuticals B.V. | Method for culturing and preserving Eubacterium hallii |
| SG11201807023QA (en) | 2016-02-25 | 2018-09-27 | Caelus Pharmaceuticals B V | Compositions and methods for preventing and/or treating vitamin b12 deficiency |
| WO2019157566A1 (en) * | 2018-02-16 | 2019-08-22 | St Vincent's Hospital (Melbourne) Limited | Compositions and methods for promoting gut health |
| JP2022530384A (ja) * | 2019-04-22 | 2022-06-29 | ペンデュラム セラピューティクス， インコーポレイテッド | より高い耐容性および延長された貯蔵寿命のための微生物組成物および方法 |
| WO2021127494A2 (en) * | 2019-12-20 | 2021-06-24 | Pendulum Therapeutics, Inc. | Methods and compositions comprising a bacteria with increased viability and faster revivability |
| FR3118059B1 (fr) * | 2020-12-18 | 2024-08-30 | Univ Bourgogne | Milieu de culture, procede de fabrication et procede de culture bacterienne |
| CN115493919B (zh) * | 2022-11-21 | 2023-04-07 | 保定佳瑞源生物芯片有限公司 | 一种c肽和胰岛素检测试剂盒的校准品稀释液 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
| US5902578A (en) | 1996-03-25 | 1999-05-11 | Abbott Laboratories | Method and formula for the prevention of diarrhea |
| US6224863B1 (en) | 1998-10-30 | 2001-05-01 | University Of South Carolina | Antibiotic composition from alcaligenes species and method for making and using the same |
| EP1228769A1 (de) | 2001-02-02 | 2002-08-07 | Jörg-Peter Prof. Schür | Symbiontisches Regenerativum |
| GB0307026D0 (en) | 2003-03-27 | 2003-04-30 | Rowett Res Inst | Bacterial supplement |
| US20080069861A1 (en) | 2006-09-19 | 2008-03-20 | National Starch And Chemical Investment Holding Corporation | Probiotic/Non-Probiotic Combinations |
| EP2102350A4 (en) | 2006-12-18 | 2012-08-08 | Univ St Louis | INTESTINAL MICROBIOMA AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR OBESITY-RELATED DISORDER |
| CN101496819A (zh) * | 2008-01-31 | 2009-08-05 | 青岛东海药业有限公司 | 真杆菌、梭菌制剂及其应用 |
| US9603876B2 (en) | 2008-09-25 | 2017-03-28 | New York University | Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment |
| EP2486143A1 (en) | 2009-10-05 | 2012-08-15 | AAK Patent B.V. | Methods for diagnosing irritable bowel syndrome |
| WO2011145516A1 (ja) | 2010-05-18 | 2011-11-24 | エイブル株式会社 | メタン生成の抑制方法 |
| WO2012142605A1 (en) | 2011-04-15 | 2012-10-18 | Samaritan Health Services | Rapid recolonization deployment agent |
| WO2013032328A1 (en) * | 2011-08-30 | 2013-03-07 | Academisch Medisch Centrum | Method for preventing and/or treating insulin resistance |
| EP2967077A4 (en) | 2013-03-15 | 2016-09-14 | Seres Therapeutics Inc | MICROBIAL COMPOSITIONS AND ASSOCIATED METHODS BASED ON A NETWORK |
| EP3881680A1 (en) * | 2014-10-31 | 2021-09-22 | Pendulum Therapeutics, Inc. | Methods and compositions relating to microbial treatment |
| AU2017204717A1 (en) | 2015-12-31 | 2018-08-02 | Caelus Pharmaceuticals B.V. | Method for culturing and preserving Eubacterium hallii |
-
2017
- 2017-01-02 AU AU2017204717A patent/AU2017204717A1/en not_active Abandoned
- 2017-01-02 KR KR1020187021375A patent/KR20180091100A/ko unknown
- 2017-01-02 RU RU2018127184A patent/RU2737398C1/ru active
- 2017-01-02 CN CN201780005598.5A patent/CN108699509A/zh active Pending
- 2017-01-02 WO PCT/NL2017/050001 patent/WO2017116235A1/en active Application Filing
- 2017-01-02 BR BR112018013292A patent/BR112018013292A2/pt not_active IP Right Cessation
- 2017-01-02 JP JP2018532242A patent/JP2019500035A/ja active Pending
- 2017-01-02 SG SG11201804847UA patent/SG11201804847UA/en unknown
- 2017-01-02 EP EP17701754.8A patent/EP3397748B1/en active Active
- 2017-01-02 CA CA3008156A patent/CA3008156C/en active Active
- 2017-01-02 DK DK17701754.8T patent/DK3397748T3/da active
- 2017-01-02 US US16/060,902 patent/US10806758B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10806758B2 (en) | 2020-10-20 |
| US20190151377A1 (en) | 2019-05-23 |
| CN108699509A (zh) | 2018-10-23 |
| EP3397748B1 (en) | 2021-03-03 |
| BR112018013292A2 (pt) | 2018-12-04 |
| AU2017204717A1 (en) | 2018-08-02 |
| CA3008156A1 (en) | 2017-07-06 |
| JP2019500035A (ja) | 2019-01-10 |
| EP3397748A1 (en) | 2018-11-07 |
| CA3008156C (en) | 2022-05-10 |
| SG11201804847UA (en) | 2018-07-30 |
| WO2017116235A1 (en) | 2017-07-06 |
| KR20180091100A (ko) | 2018-08-14 |
| RU2737398C1 (ru) | 2020-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3386534T3 (da) | Sammensætninger og fremgangsmåder til internalisering af enzymer | |
| DK3325669T3 (da) | Sammensætninger og fremgangsmåder til RNA-analyse | |
| DK3390631T3 (da) | Fremgangsmåder og sammensætninger til t-rna-baseret guide-rna-ekspression | |
| DK3319952T3 (da) | Fremgangsmåde til fremstilling af cannabidiol og delta-9-tetrahydrocannabinol | |
| DK3353299T3 (da) | Fremgangsmåder og stoffer til målrettet rna-editering | |
| DK3386550T3 (da) | Fremgangsmåder til fremstilling og anvendelse af guide nukleinsyrer | |
| DK3215601T3 (da) | Fremgangsmåder til transduktion og celleforarbejdning | |
| DK3292134T3 (da) | Metode til dyrkning af akkermansia | |
| DK3137605T3 (da) | Sammensætninger og fremgangsmåder til modulering af angiopoietin-lignende-3-ekspression | |
| DK3125927T3 (da) | Fremgangsmåder og sammensætninger til immunmodulering | |
| DK3279310T3 (da) | Celledyrkningsapparat og fremgangsmåde til celledyrkning | |
| DK3368663T3 (da) | Virusfri cellelinjer og fremgangsmåder til opnåelse deraf | |
| DK3394065T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf | |
| DK3359281T3 (da) | Fremgangsmåde til udtrækning af CO2 | |
| DK3397748T3 (da) | Fremgangsmåde til dyrkning og konservering af Eubacterium hallii | |
| DK3519572T5 (da) | Forbindelser og fremgangsmåder til reduktion af tau-ekspression | |
| DK3394259T3 (da) | Sammensætninger og fremgangsmåder til reducering af tau-ekspression | |
| DK2924093T3 (da) | Multicarboxylat-sammensætninger og fremgangsmåde til fremstilling af disse | |
| DK3102232T3 (da) | Fremgangsmåder og sammensætninger til behandling af abnorm cellevækst | |
| DK3170632T3 (da) | Fremgangsmåde og anordning til opskæring af fødevareprodukter | |
| DK3367852T3 (da) | Indretning og fremgangsmåde til behandling af levnedsmidler | |
| DK3167076T3 (da) | Fremgangsmåder og produkter til kvantificering af RNA-transkriptvarianter | |
| DK3368578T3 (da) | Anti-HtrA1-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3357343T3 (da) | Fedtsammensætning og fremgangsmåde til fremstilling heraf | |
| DK3247196T3 (da) | Apparat og metode til plantning af plantestiklinger |